Covered recipient · General Payments record
THEODORE C FRIEDMAN
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$2,857.39
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $407.12 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $343.09 | 7 |
| Abbott Laboratories | $33.02 | 1 |
| DEXCOM, INC. | $17.58 | 1 |
| Avion Pharmaceuticals | $13.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $33.02 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125365486 | CMS |
| Avion Pharmaceuticals | $13.43 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126645456 | CMS |
| Dexcom, Inc. | $17.58 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153340335 | CMS |
| Novo Nordisk Inc | $19.35 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097819600 | CMS |
| Novo Nordisk Inc | $22.48 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097408657 | CMS |
| Novo Nordisk Inc | $121.04 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097728198 | CMS |
| Novo Nordisk Inc | $127.41 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096959810 | CMS |
| Novo Nordisk Inc | $19.29 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097411049 | CMS |
| Novo Nordisk Inc | $14.11 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097246536 | CMS |
| Novo Nordisk Inc | $19.41 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097472426 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.